Seong-Chul Kim
Director/Board Member at KPS CORPORATION
Net worth: 3 M $ as of 30/04/2024
Profile
Seong-Chul Kim is the founder of Elevar Therapeutics, Inc. which was founded in 2005.
He held the titles of President, Chief Executive Officer & Director.
Currently, he is a Director at KPS Corp.
(South Korea) where he still holds a job.
In the past, he worked as Co-Chief Executive Officer at LSK Investment Co. Ltd.
from 2016 to 2018 and as Director & Head-Bio at HLB Co., Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KPS CORP
2.94% | 03/04/2024 | 550,458 ( 2.94% ) | 3 M $ | 30/04/2024 |
Seong-Chul Kim active positions
| Companies | Position | Start |
|---|---|---|
| KPS CORPORATION | Director/Board Member | - |
Former positions of Seong-Chul Kim
| Companies | Position | End |
|---|---|---|
LSK Investment Co. Ltd.
 LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Chief Executive Officer | 31/12/2018 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Founder | - |
| HLB CO., LTD. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HLB CO., LTD. | Health Technology |
| KPS CORPORATION | Electronic Technology |
| Private companies | 2 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
- Stock Market
- Insiders
- Seong-Chul Kim
